CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis

CRD-BP 介导的 Wnt 信号在肠道肿瘤发生中的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Colorectal cancer is one of the most lethal of all cancers. One of the major drivers underlying the development of colorectal tumors is the Wnt/ß-catenin signaling pathway. We have previously established CRD-BP as a bona fide transcriptional target of Wnt signaling pathway and demonstrated that induction of CRD-BP is responsible for a variety of pleiotropic effects of Wnt/ß-catenin signaling in human colorectal cancer cells. We have demonstrated that: i) c-myc up-regulation by Wnt/ß-catenin signaling depends on CRD-BP; ii) CRD-BP facilitates cross-talk between Wnt and NF-κB pathways; iii) CRD-BP mediates activation of GLI1 transcriptional activity in response to Wnt signaling independently of Hh signaling pathway; iv) CRD-BP is transcriptionally regulated by c-myc and is involved in several functions of c-myc proto-oncogene, including regulation on translation, cell size, cell cycle progression, and cell proliferation; v) we have also uncovered a mechanism of CRD-BP-mediated stabilization of ßTrCP1 mRNA. We hypothesize that CRD-BP plays a central role in the modulation of Wnt/ß-catenin signaling in the oncogenic transformation of intestinal epithelia, including its role in the maintenance, self-renewal, differentiation, and transformation of intestinal epithelial stem cells (IESCs). We propose to study the mechanisms of CRD-BP involvement in intestinal tumorigenesis. Pursuant to these goals, our specific aims are: 1. To analyze the role of CRD-BP in the regulation of Wnt signaling in CRC cells. 2. To elucidate the mechanisms of CRD-BP function in intestinal tumorigenesis. Overall, the completion of the proposed studies will help elucidate the role of CRD-BP in colorectal carcinogenesis. It will also delineate the mechanisms of regulation and function of CRD-BP in these tumors. These studies may potentially lead to the design of agents capable of inhibiting CRD-BP that might be utilized in the therapy of CRC.
描述(由适用提供):大肠癌是所有癌症中最致命的癌症之一。彩色肿瘤发展的主要驱动因素之一是Wnt/ß-catenin信号通路。我们以前已经将CRD-BP建立为Wnt信号通路的真正转录靶标,并证明CRD-BP的诱导是造成Wnt/ß-catenin信号在人类结直肠癌细胞中的多种多效性效应。我们已经证明:i)Wnt/ß-catenin信号通过Wnt/ß-catenin信号上调取决于CRD-BP; ii)CRD-BP支持Wnt和NF-κB路径之间的串扰; iii)CRD-BP介导Gli1转录活性的激活,响应于HH信号通路独立于Wnt信号; iv)CRD-BP在转录上受C-Myc调节,并参与了C-Myc原始癌的多种功能,包括对翻译的调节,细胞的调节 大小,细胞周期进程和细胞增殖; v)我们还发现了CRD-BP介导的βTrCP1mRNA稳定的机制。我们假设CRD-BP在Wnt/ß-catenin信号传导的调节中起着核心作用 肠上皮干细胞(IESC)。我们建议研究CRD-BP参与肠道肿瘤发生的机制。根据这些目标,我们的具体目的是:1。分析CRD-BP在CRC细胞中Wnt信号传导调节中的作用。 2。阐明CRD-BP功能在肠道肿瘤发生中的机制。总体而言,提出的研究的完成将有助于阐明CRD-BP在结直肠癌发生中的作用。它还将描述这些肿瘤中CRD-BP调节和功能的机理。这些研究可能会导致设计能够抑制CRD-BP的药物的设计,而CRD BP可能用于CRC治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vladimir S. Spiegelman其他文献

RNA-Binding Protein IGF2BP1 in Cutaneous Squamous Cell Carcinoma
  • DOI:
    10.1016/j.jid.2016.10.042
  • 发表时间:
    2017-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    TaeWon Kim;Thomas Havighurst;KyungMann Kim;Scott J. Hebbring;Zhan Ye;Juliet Aylward;Sunduz Keles;Yaohui G. Xu;Vladimir S. Spiegelman
  • 通讯作者:
    Vladimir S. Spiegelman

Vladimir S. Spiegelman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vladimir S. Spiegelman', 18)}}的其他基金

Role and mechanisms of IGF2BP1 in melanoma pathogenesis
IGF2BP1在黑色素瘤发病机制中的作用和机制
  • 批准号:
    10530604
  • 财政年份:
    2019
  • 资助金额:
    $ 17.01万
  • 项目类别:
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
IGF2BP1在黑色素瘤发病机制中的作用和机制
  • 批准号:
    10304172
  • 财政年份:
    2019
  • 资助金额:
    $ 17.01万
  • 项目类别:
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
IGF2BP1在黑色素瘤发病机制中的作用和机制
  • 批准号:
    10064140
  • 财政年份:
    2019
  • 资助金额:
    $ 17.01万
  • 项目类别:
Role and mechanisms of IGF2BP1 in melanoma pathogenesis
IGF2BP1在黑色素瘤发病机制中的作用和机制
  • 批准号:
    9911798
  • 财政年份:
    2019
  • 资助金额:
    $ 17.01万
  • 项目类别:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
CRD-BP 介导的 Wnt 信号在肠道肿瘤发生中的调节
  • 批准号:
    8813074
  • 财政年份:
    2014
  • 资助金额:
    $ 17.01万
  • 项目类别:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
CRD-BP 介导的 Wnt 信号在肠道肿瘤发生中的调节
  • 批准号:
    8974822
  • 财政年份:
    2014
  • 资助金额:
    $ 17.01万
  • 项目类别:
RNA-binding protein CRD-BP in melanocyte biology
黑素细胞生物学中的 RNA 结合蛋白 CRD-BP
  • 批准号:
    9088551
  • 财政年份:
    2013
  • 资助金额:
    $ 17.01万
  • 项目类别:
RNA-binding protein CRD-BP in melanocyte biology
黑素细胞生物学中的 RNA 结合蛋白 CRD-BP
  • 批准号:
    8437734
  • 财政年份:
    2013
  • 资助金额:
    $ 17.01万
  • 项目类别:
RNA-binding protein CRD-BP in melanocyte biology
黑素细胞生物学中的 RNA 结合蛋白 CRD-BP
  • 批准号:
    8996553
  • 财政年份:
    2013
  • 资助金额:
    $ 17.01万
  • 项目类别:
RNA-binding protein CRD-BP in melanocyte biology
黑素细胞生物学中的 RNA 结合蛋白 CRD-BP
  • 批准号:
    9208744
  • 财政年份:
    2013
  • 资助金额:
    $ 17.01万
  • 项目类别:

相似海外基金

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
鳞状癌中成纤维细胞生长因子受体的治疗靶向
  • 批准号:
    9754787
  • 财政年份:
    2015
  • 资助金额:
    $ 17.01万
  • 项目类别:
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
鳞状癌中成纤维细胞生长因子受体的治疗靶向
  • 批准号:
    8938887
  • 财政年份:
    2015
  • 资助金额:
    $ 17.01万
  • 项目类别:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
CRD-BP 介导的 Wnt 信号在肠道肿瘤发生中的调节
  • 批准号:
    8813074
  • 财政年份:
    2014
  • 资助金额:
    $ 17.01万
  • 项目类别:
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis
CRD-BP 介导的 Wnt 信号在肠道肿瘤发生中的调节
  • 批准号:
    8974822
  • 财政年份:
    2014
  • 资助金额:
    $ 17.01万
  • 项目类别:
Integrin Targeted Therapy for the Treatment of Ovarian Cancer
整合素靶向治疗卵巢癌
  • 批准号:
    8395111
  • 财政年份:
    2012
  • 资助金额:
    $ 17.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了